Chapter 61 - 4 Investments Done
Gray sat up straighter in his chair. His eyes were tired, and his back ached a little from leaning over his laptop all evening, but he finally felt like he was making progress.
After hours of reading through financial articles, business reports, and stock history charts, he had narrowed his list down to four companies. Each one had its own strengths and risks. Each one, if he was right, could help him reach that $100,000 goal.
He took a breath and clicked into the first tab.
NexGene Diagnostics
This one was a gamble but a smart one.
NexGene Diagnostics was a small biotech company in the southern provinces. Their focus? Portable medical devices that could quickly detect diseases like infections or viruses. These devices were affordable, fast, and easy to use—even in small, rural towns with little access to hospitals.
Gray had read an article earlier that week. NexGene had already tested their product in three remote towns, and the results were promising. So promising, in fact, that the government stepped in and gave them funding to keep going.
That kind of support wasn’t easy to get so it already speaks of one thing.
"They might be small," Gray said, clicking through their investment page, "but they’ve got a good cause and backing. That’s already a strong start."
NexGene wasn’t a public company yet—he couldn’t just buy their stocks on the market like most others. Instead, they were offering private shares in what was called a Series B round.
That meant they had already passed the early idea stage, had a working product, and now needed more money to grow big.